FibroBiologics Advances Innovative Cell Therapy: FDA Review of CYPS317 for Psoriasis Treatment Marks Major Clinical Milestone
- January 12, 2026
It Was All a Dream
Geri’s Complicated Journey with Lupus, Sjogren’s and Non-Hodgkins Lymphoma
From Cancer Treatment to Childhood Health: How Foresee’s Injectable Drug Addresses a Rare Pediatric Challenge
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
FibroBiologics Advances Innovative Cell Therapy: FDA Review of CYPS317 for Psoriasis Treatment Marks Major Clinical Milestone bit.ly/4jtkoXK Read now at PatientWorthy.com
#PatientWorthy #psoriasis #clinicaltrials #cyps317
Getting a diagnosis can feel overwhelming, especially when the process moves quickly. Understanding why certain tests are done and how treatment decisions are made can help bring a little clarity to a very uncertain moment.
This post walks through the big picture — but everyone’s path with DLBCL is personal. Questions are valid, second opinions are okay, and support matters at every step! If you're interested in sharing your story with DLBCL, click here: bit.ly/4dV7gru
#DLBCL #Lymphoma #ShareYourStory #PatientWorthy
Today we recognize Paget’s Disease Awareness Day, shining a light on a rare and often misunderstood condition. Increased awareness leads to earlier diagnosis, better care, and stronger support for those affected. #PagetsDisease #PatientWorthy #RareDisease
#ShareYourStory here: bit.ly/4dV7gru
